HIV/AIDS in Africa
Diet, a Potent Weapon Against HIV
Nutrition plays an important role in the health of People Living with HIV/Aids
(PLWAs).
HIV/AIDS plan moving too slowly
Government's Clinica Esperanca in Luanda (Angola) supplies free ARVs
Brain Drain in Africa Stalls Anti-HIV Campaign
The brain drain of nurses and doctors in African countries is jeopardising the global fight against HIV/AIDS.
ARVs: Ball in Corporate World's Court
ZIMBABWE'S corporate sector needs to take serious steps to help workers access anti-retroviral drugs to ensure the sustainability of the country's fight against the HIV and Aids pandemic, analysts say.
Working Group Recommends Integrative Approach to HIV
The Global HIV Prevention Working Group released its third report today, recommending the integration of HIV/Aids treatment and prevention programs to reduce the rate of HIV transmission and treat those already infected with HIV, an effort they say requires tripling current HIV/Aids spending over the next three years.
Investors take Aids fight beyond drug firms
New Jersey - A coalition of faith-based investor groups said yesterday that it would expand its efforts to fight HIV/Aids by putting pressure on firms employing people in the hardest-hit countries.
Calls for decentralisation of ARV programmes
A government decision to distribute anti-AIDS drugs at two of Zimbabwe's largest urban hospitals has been criticised because the majority of people in need of antiretroviral (ARV) drugs live in rural areas.
SOUTHERN AFRICA: Five NGOs to receive USAID grants for HIV/AIDS programmes
Five NGOs running HIV/AIDS-related programmes in Southern Africa are to receive a portion of US 350 million grant from the United States Agency for the International Development (USAID) under the President's Emergency Plan for AIDS Relief (PEPFAR).
New agreements aim to make lowest-cost AIDS drugs and diagnostics available to hundreds of thousands in developing world
The Global Fund, the World Bank, UNICEF and the Clinton Foundation today announced agreements that will make it possible for developing countries to purchase high-quality AIDS medicines and diagnostics at the lowest available prices, in many cases for more than fifty percent less than is currently available



